pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy
Narcolepsy is a debilitating sleep disorder that presents with excessive daytime sleepiness (EDS) and cataplexy, which is a sudden paralysis of muscle tone triggered by strong emotions such as laughing. It is also associated with many other disorders, including psychiatric disorders, neurologic illn...
Saved in:
Main Authors: | Noeen Sarfraz, David Okuampa, Hannah Hansen, Mark Alvarez, Elyse M. Cornett, Juyeon Kakazu, Adam M. Kaye, Alan D. Kaye |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2022-05-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.34222 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The extent of sleep deprivation and daytime sleepiness in young adults
by: Alexandra Rubin, et al.
Published: (2023-05-01) -
Longer respiratory events in childhood obstructive sleep apnea syndrome constitute a trait of older children with excessive daytime sleepiness
by: Plamen Bokov, et al.
Published: (2025-02-01) -
Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
by: Andrew H. Han, et al.
Published: (2023-01-01) -
deutetrabenazine for the treatment of chorea associated with Huntington’s disease
by: Harshit Gupta, et al.
Published: (2022-06-01) -
Glossopharyngeal Neuralgia: Epidemiology, Risk factors, Pathophysiology, Differential diagnosis, and Treatment Options
by: Andrew Han, et al.
Published: (2022-06-01)